Design of the RELAXin in Acute Heart Failure StudyPONIKOWSKI, Piotr; METRA, Marco; MUELLER-VELTEN, Guenther et al.The American heart journal. 2012, Vol 163, Num 2, pp 149-155, issn 0002-8703, 7 p.Article

Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF) : a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase lib studyTEERLINK, John R; METRA, Marco; TEICHMAN, Sam L et al.Lancet (British edition). 2009, Vol 373, Num 9673, pp 1429-1439, issn 0140-6736, 11 p.Article

Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adultsTEICHMAN, Sam L; NEALE, Ann; LAWRENCE, Betty et al.The Journal of clinical endocrinology and metabolism. 2006, Vol 91, Num 3, pp 799-805, issn 0021-972X, 7 p.Article

Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program: Correlation With OutcomesMETRA, Marco; COTTER, Gad; DOROBANTU, Maria I et al.Journal of the American College of Cardiology. 2013, Vol 61, Num 2, pp 196-206, issn 0735-1097, 11 p.Article

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trialTEERLINK, John R; COTTER, Gad; DOROBANTU, Maria I et al.Lancet (British edition). 2013, Vol 381, Num 9860, pp 29-39, issn 0140-6736, 11 p.Article